Equine

EquiCoxib® (firocoxib)

9 mg/mL firocoxib

EquiCoxib® (firocoxib) is an FDA-approved 0.9% oral solution for horses for the treatment of pain and inflammation associated with osteoarthritis. This flavorless, odorless liquid simplifies weight-based dosing, ensuring precise administration for horses of varying sizes.

Package Presentation

90 mL
Reorder No.28008
400 mL
Reorder No.28009

Key Features

  • Proven pharmacokinetic, bioequivalence to Equioxx® Paste in a blinded, controlled cross-over study
  • Accurate dosing based on the actual weight of the horse
  • Newly designed draw-off-cap and syringe for easier, economical dispensing
  • Approved by FDA under ANADA 200-766
  • Manufactured under GMP standards for quality and consistency

Safety Information

FOR ORAL USE IN HORSES ONLY. DO NOT INJECT EQUICOXIB. ONLY ADMINISTER WITH THE PROVIDED DOSING SYRINGE. Do not use in horses intended for human consumption.

EquiCoxib® is contraindicated in horses with a hypersensitivity to firocoxib. As with any prescription medication, prior to use, a veterinarian should perform a physical examination and review the horse’s medical history. Treatment with EquiCoxib® should be terminated if signs such as inappetence, colic, abnormal feces, or lethargy are observed. As a class, nonsteroidal anti-inflammatory drugs may be associated with gastrointestinal, hepatic and renal toxicity. Use with other NSAIDs, corticosteroids or nephrotoxic medication should be avoided. EquiCoxib® has not been evaluated in horses less than 1 year of age or in breeding horses, or pregnant or lactating mares.

Not for use in humans. Keep this and all medications out of the reach of children. Wash hands with soap and water after use. Consult a physician in case of accidental ingestion by humans.

For complete safety information, refer to the package insert.

Equioxx is a registered trademark of Elanco.